Prochlorperazine Edisylate Injection
Product Images NDC 25021-790

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 25021-790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Pro22 0000 01)

Chemical structure of prochlorperazine edisylate showing its molecular components and arrangement, including rings, functional groups, and associated sulfonic acid moieties.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Pro22 0000 02)

Label for Prochlorperazine Edisylate Injection, USP with a concentration of 10 mg per 2 mL (5 mg per mL) in a 2 mL multi-dose vial. Intended for deep intramuscular or intravenous use only, not for subcutaneous use. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, made in India. Storage instructions and barcode are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.